List of Contributors.
PART 1: INTRODUCTION.
1. Vaccination: Past, Present and Future (Maria Lattanzi and Rino Rappuoli).
2. Bioinformatics, DNA Microarrays and Proteomics in Vaccine Discovery: Competing or Complementary Technologies? (Guido Grandi).
PART 2: TECHNOLOGIES.
3. Genome Sequencing and Analysis (Hervé Tettelin and Tamara Feldblyum).
4. Understanding DNA Microarrays: Sources and Magnitudes of Variances in DNA Microarray Data Sets (She-pin Hung, G. Wesley Hatfield, Suman Sundaresh and Pierre F. Baldi).
5. The proteome, Anno Domini Two Zero Zero Three (Pier Giorgio Righetti, Mahmoud Hamdan, Frederic Reymond and Joël S. Rossier).
6. Mass Spectrometry in Proteomics (Pierre-Alain Binz).
7. High Throughput Cloning, Expression and Purification Technologies (Andreas Kreusch and Scott A. Lesley).
PART 3: APPLICATIONS.
8. Meningococcus B: from Genome to Vaccine (Davide Serruto, Rino Rappuoli and Mariagrazia Pizza).
9. Vaccines Against Pathogenic Streptococci (John L. Telford, Immaculada Margarit y Ros, Domenico Maione, Vega Masignani, Hervé Tettelin, Giuliano Bensi and Guido Grandi).
10. Identification of the 'Antigenome'–a Novel Tools for Design and Development of Subunit Vaccines Against Bacterial Pathogens (Eszter Nagy, Tamás Henics, Alexander von Gabain and Andreas Meinke).
11. Searching the Chlamydia Genomes for New Vaccine Candidates (Giulio Ratti, Oretta Finco and Guido Grandi).
12. Proteomics and Anti-Chlamydia Vaccine Discovery (Gunna Christiansen, Svend Birkelund, Brian B. Vandahl and Allan C Shaw).
13. Proteome Analysis of Other Membrane and Extracelular Proteins from Pseudomonas aeruginosa for vaccine Discovery (Stuart J. Cordwell and Amanda S. Nouwens).
"…an excellent book on a topical issue that will appeal to research scientists looking to find new and alternative means of designing and developing vaccines." (ASM News, March 2005)
"...chapters are written by experts in the field...new data is provided as well as descriptions of their biology..." (CAB Publishing, 2004)
"...should be of interest to all those working in vaccine discovery and development in pharmaceutical and biotechnology companies as well as in academic institutions." (The Biotech Journal, November/December 2003)